What is behind Bone & Joint Strength
Living tissue in permanent turnover — built by osteoblasts, dismantled by osteoclasts, with rankl and osteoprotegerin setting the balance. Density is the running total of that contest, not a fixed property. Evidence A — Human trial evidence.
Cartilage, synovium, subchondral bone and the tissues that load them. A finding the evidence shows: joint pain and joint structure come apart — pain 'may not correlate with inflammation or structural damage', so an intervention can help one and not the other. Evidence B — Preclinical.
Tissue structure and remodeling. Evidence A — Human trial evidence.
RANKL drives osteoclast maturation; opg is its decoy receptor. The ratio sets bone turnover. Evidence A — Human trial evidence.
Far more than a reproductive hormone — it guards bone density, vascular flexibility and skin collagen. Its withdrawal at menopause is the single largest hormonal event in human physiology, with consequences traced across five systems. Evidence A — Human trial evidence.
The protease osteoclasts use to actually cut bone apart. Cathepsin K is the principal enzyme responsible for degrading bone collagen, and it degrades both of the collagens that matter here — type I in bone and type II in cartilage. Evidence A — Human trial evidence.
Hepatocyte proliferation — the liver's remarkable capacity to regenerate and restore its own mass. Evidence A — Human trial evidence.
The master inflammatory switch — indispensable to defend against threat, corrosive when it never stands down. Evidence B — Preclinical.
Estrogen balance — set largely by the aromatase enzyme that converts androgens into estrogen — shapes reproductive, bone, skin and metabolic health. The aim is healthy balance for the individual, not simply more or less. Evidence A — Human trial evidence.
Evidence on these pathways
Cathepsin K (bone collagenase) → Joint Function. “we describe the function of cathepsin K and its effect on cartilage degradation via type II collagen cleavage.” — Cathepsin K Inhibitors as Potential Drugs for the Treatment of Osteoarthritis. International Journal of Molecular Sciences; 2025; volume 26; issue 7; article number 2896. doi:10.3390/ijms26072896
NF-κB → CD38 NADase. “Regulation of CD38 expression in HASM cells involves the transcription factor NF-κB, and glucocorticoids inhibit this expression through NF-κB-dependent and -independent mechanisms.” — Regulation of the cd38 promoter in human airway smooth muscle cells by TNF-α and dexamethasone. Respiratory Research, 2008, vol 9, 26. doi:10.1186/1465-9921-9-26
NF-κB → COX-2 Induction. “Moreover, the nuclear factor kappa B (NF-κB) inhibitor BAY11‐7085 or the TLR4 neutralizing antibody markedly blocked PM2.5-induced IL-6 and COX-2 expression.” — PM2.5 exposure upregulates pro-inflammatory protein expression in human microglial cells via oxidant stress and TLR4/NF-κB pathway. Ecotoxicology and Environmental Safety, 2024, vol 277, article 116386. doi:10.1016/j.ecoenv.2024.116386
NF-κB → Kynurenine Pathway. “Treatment of vaccinated DCs with pharmacological NF-κB inhibitors ACHP or DHMEQ significantly inhibited IDO1 biosynthesis, suggesting a role for NF-κB signaling in vaccine up-regulation of dendritic cell IDO1.” — Induction of Indoleamine 2, 3-Dioxygenase in Human Dendritic Cells by a Cholera Toxin B Subunit—Proinsulin Vaccine. PLoS ONE, 2015, volume 10, e0118562. doi:10.1371/journal.pone.0118562
Formulas that act on these pathways
Acts on 6 of these pathways: Bone Density, Joint Function, RANKL / OPG Ratio, Cathepsin K (bone collagenase), Hepatocyte Proliferation, NF-κB.
Acts on 3 of these pathways: Joint Function, Estrogen, NF-κB.
Acts on 2 of these pathways: RANKL / OPG Ratio, NF-κB.
Acts on 2 of these pathways: Hepatocyte Proliferation, NF-κB.
What this page does not claim
This page names the pathways involved and the published evidence on each. It does not claim that any formula treats, cures or prevents Bone & Joint Strength. A pathway opens here only on graded, published evidence, under a standard fixed before the evidence was gathered, and every figure above carries its grade.
These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.